From: Systems analysis of inflammatory bowel disease based on comprehensive gene information
IBD state | Category | Drug name | Indication | ||
---|---|---|---|---|---|
 |  |  | US | UK | Japan |
Mild | Amino-salicylate | Mesalazine | UC, CD | UC, CD | UC, CD |
 |  | Salazo-sulfapyridine | UC, CD, RA | UC, CD, RA | UC, CD, RA |
 |  | Olsalazine | UC | UC | - |
 |  | Balsalazide | UC | UC | - |
Moderate | Immuno-modulators | Azathioprine | RA, GVHD | RA, SLE, DM, AICAH, PM, PV, PN, AHA ITP | GVHD, CD |
 |  | Tacrolimus | PTR | PTR | PTR, GVHD, MG, RA, LN, UC |
 | Corticosteroids | Budesonide (Entocort only) | CD | CD | - |
 |  | Prednisolone | RA, UC (chronic), Nephrotic Syndrome, Collagen Diseases, Fulminating SLE, Allergic Conditions, Bronchial Asthma, Acute Skin Diseases, Thrombocytopenia, Organ transplantation. | ||
Severe | Anti-TNF antibody | Infliximab | UC, CD, RA, PS, AS | UC, CD, RA, PS, AS | UC, CD, RA, PS, AS, BD |
 |  | Adalimumab | CD, RA, PS, AS | CD, RA, PS, AS | - |
 |  | Certolizumab | CD, RA | RA | - |